TRI13_HUMAN - dbPTM
TRI13_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TRI13_HUMAN
UniProt AC O60858
Protein Name E3 ubiquitin-protein ligase TRIM13
Gene Name TRIM13
Organism Homo sapiens (Human).
Sequence Length 407
Subcellular Localization Endoplasmic reticulum membrane
Single-pass membrane protein . Concentrates and colocalizes with p62/SQSTM1 and ZFYVE1 at the perinuclear endoplasmic reticulum.
Protein Description Endoplasmic reticulum (ER) membrane anchored E3 ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. Enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal degradation. Regulates ER stress-induced autophagy, and may act as a tumor suppressor. [PubMed: 22178386 Plays also a role in innate immune response by stimulating NF-kappa-B activity in the TLR2 signaling pathway. Ubiquitinates TRAF6 via the 'Lys-29'-linked polyubiquitination chain resulting in NF-kappa-B activation]
Protein Sequence MELLEEDLTCPICCSLFDDPRVLPCSHNFCKKCLEGILEGSVRNSLWRPAPFKCPTCRKETSATGINSLQVNYSLKGIVEKYNKIKISPKMPVCKGHLGQPLNIFCLTDMQLICGICATRGEHTKHVFCSIEDAYAQERDAFESLFQSFETWRRGDALSRLDTLETSKRKSLQLLTKDSDKVKEFFEKLQHTLDQKKNEILSDFETMKLAVMQAYDPEINKLNTILQEQRMAFNIAEAFKDVSEPIVFLQQMQEFREKIKVIKETPLPPSNLPASPLMKNFDTSQWEDIKLVDVDKLSLPQDTGTFISKIPWSFYKLFLLILLLGLVIVFGPTMFLEWSLFDDLATWKGCLSNFSSYLTKTADFIEQSVFYWEQVTDGFFIFNERFKNFTLVVLNNVAEFVCKYKLL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
32UbiquitinationCSHNFCKKCLEGILE
CCCCHHHHHHHHHHH
45.28-
35 (in isoform 3)Ubiquitination-54.37-
45PhosphorylationLEGSVRNSLWRPAPF
HHCCHHHCCCCCCCC
20.8124719451
53UbiquitinationLWRPAPFKCPTCRKE
CCCCCCCCCCCCCCC
37.94-
56 (in isoform 3)Ubiquitination-34.12-
74PhosphorylationNSLQVNYSLKGIVEK
CCCEEEEEHHHHHHH
20.5724719451
81UbiquitinationSLKGIVEKYNKIKIS
EHHHHHHHHHCCCCC
43.14-
90UbiquitinationNKIKISPKMPVCKGH
HCCCCCCCCCCCCCC
49.39-
125UbiquitinationATRGEHTKHVFCSIE
CCCCCCCEEEEEEHH
39.41-
128 (in isoform 3)Ubiquitination-2.43-
166PhosphorylationSRLDTLETSKRKSLQ
HHHHHHHHHHHHHHH
42.53-
167PhosphorylationRLDTLETSKRKSLQL
HHHHHHHHHHHHHHH
22.53-
168 (in isoform 1)Ubiquitination-71.8621906983
168UbiquitinationLDTLETSKRKSLQLL
HHHHHHHHHHHHHHH
71.8621906983
170UbiquitinationTLETSKRKSLQLLTK
HHHHHHHHHHHHHHC
60.29-
171 (in isoform 2)Ubiquitination-25.9421906983
171 (in isoform 3)Ubiquitination-25.94-
171PhosphorylationLETSKRKSLQLLTKD
HHHHHHHHHHHHHCC
25.9429214152
173 (in isoform 3)Ubiquitination-41.33-
174PhosphorylationSKRKSLQLLTKDSDK
HHHHHHHHHHCCHHH
8.7627251275
176PhosphorylationRKSLQLLTKDSDKVK
HHHHHHHHCCHHHHH
41.20-
183UbiquitinationTKDSDKVKEFFEKLQ
HCCHHHHHHHHHHHH
55.32-
186 (in isoform 3)Ubiquitination-9.44-
188UbiquitinationKVKEFFEKLQHTLDQ
HHHHHHHHHHHHHHH
48.57-
192PhosphorylationFFEKLQHTLDQKKNE
HHHHHHHHHHHHHHH
21.0429396449
196UbiquitinationLQHTLDQKKNEILSD
HHHHHHHHHHHHHHH
58.18-
202PhosphorylationQKKNEILSDFETMKL
HHHHHHHHHHHHHHH
46.0129759185
206PhosphorylationEILSDFETMKLAVMQ
HHHHHHHHHHHHHHH
21.4329759185
208UbiquitinationLSDFETMKLAVMQAY
HHHHHHHHHHHHHHH
40.49-
221 (in isoform 1)Ubiquitination-49.1021906983
221UbiquitinationAYDPEINKLNTILQE
HHCHHHHHHHHHHHH
49.1021906983
224 (in isoform 2)Ubiquitination-33.2421906983
224 (in isoform 3)Ubiquitination-33.24-
258UbiquitinationQMQEFREKIKVIKET
HHHHHHHHCCHHCCC
43.50-
270PhosphorylationKETPLPPSNLPASPL
CCCCCCCCCCCCCCC
49.4025002506
275PhosphorylationPPSNLPASPLMKNFD
CCCCCCCCCCCCCCC
19.3425850435
279UbiquitinationLPASPLMKNFDTSQW
CCCCCCCCCCCCHHC
63.24-
290 (in isoform 1)Ubiquitination-55.5721906983
290UbiquitinationTSQWEDIKLVDVDKL
CHHCCCEEEEECCCC
55.572190698
293 (in isoform 2)Ubiquitination-54.0221906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseTRIM13O60858
PMID:31744379

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TRI13_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TRI13_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ROBO2_HUMANROBO2physical
21900206
GDIR1_HUMANARHGDIAphysical
21900206
SQSTM_HUMANSQSTM1physical
22178386
ZFYV1_HUMANZFYVE1physical
22178386
TERA_HUMANVCPphysical
17314412
AT2A2_HUMANATP2A2physical
17314412
OST48_HUMANDDOSTphysical
17314412
UB2D2_HUMANUBE2D2physical
17314412
TRI13_HUMANTRIM13physical
17314412
NEMO_HUMANIKBKGphysical
25152375
GMCL1_HUMANGMCL1physical
25416956
MDM2_HUMANMDM2physical
21333377
AKT1_HUMANAKT1physical
21333377
TRI13_HUMANTRIM13physical
21333377
ELOV2_HUMANELOVL2physical
28514442
NPL4_HUMANNPLOC4physical
28514442
CKAP4_HUMANCKAP4physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TRI13_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP